01—Abstract
Summary
Summary of the 8-K filed October 23, 2024. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. (CME) has filed an 8-K report on October 23, 2024, announcing its financial results for the quarter ended September 30, 2024.
The filing incorporates by reference a press release (Exhibit 99.1) detailing these results. A key aspect of the report is the presentation of both Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures, including non-GAAP net income and earnings per share. Management utilizes these non-GAAP measures to offer supplemental insights into the company's financial performance and business trends, aiming to enhance comparability with prior periods.
While these non-GAAP figures are presented as a supplement, the company emphasizes that they should be considered alongside, and not as a replacement for, the GAAP-based financial statements. A reconciliation of the non-GAAP measures to their most directly comparable GAAP counterparts is provided within the press release, in compliance with Regulation G.
02—Key points
Key Highlights
- CME Group Inc. reported its Q3 2024 financial results on October 23, 2024, via an 8-K filing.
- The filing includes a press release detailing the financial results for the quarter ended September 30, 2024.
- Both GAAP and non-GAAP financial measures are presented in the accompanying press release.
- Non-GAAP net income and earnings per share are provided as supplemental information.
- Management believes non-GAAP measures offer better comparability with prior financial reports and provide insights into business trends.
- Reconciliation of non-GAAP to GAAP measures is included in the press release as per Regulation G requirements.
- The information is incorporated by reference from Exhibit 99.1, the press release dated October 23, 2024.
03—Questions
Frequently Asked Questions
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to announce CME Group Inc.'s financial results for the quarter ended September 30, 2024, through an incorporated press release.
Does this filing contain the full financial statements?
This 8-K filing incorporates by reference a press release (Exhibit 99.1) which contains the company's financial results for the quarter. Investors should refer to this press release for the detailed financial information, including both GAAP and non-GAAP measures.
What are non-GAAP financial measures and why does CME Group provide them?
Non-GAAP financial measures, such as non-GAAP net income and earnings per share, are financial metrics not calculated in accordance with Generally Accepted Accounting Principles (GAAP). CME Group provides them as supplemental information to management and investors to offer a better understanding of financial and business trends and to improve comparability with prior financial reports.
Are the non-GAAP measures presented in this filing a substitute for GAAP measures?
No, CME Group states that the non-GAAP measures should be considered a supplement to, and not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. A reconciliation between the non-GAAP and GAAP figures is provided in the press release.
04—Continue